This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In fact, mental health conditions are associated with a 10- to 25-year reduction in life expectancy , emphasizing the need for effective and accessible treatments. Its integral to peoples well-being to have a good mood and motivation in daily activities with their families and work life.
The Indian lifesciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, big data, internet of things (IoT) and blockchain into their research and development efforts.
The surge in MASH cases stresses the need for early diagnosis, timely intervention and precise, reliable methodologies in clinicaltrials to evaluate new therapies effectively. Read on to gain insights from Medpace experts about advancements in imaging, histology and innovative techniques for MASH clinicaltrials.
Global rare disease clinicaltrials face unique challenges due to small patient populations, complex logistics, diverse regulatory environments and cultural differences. ClinicalTrial Manager/Sr. These measures enhance recruitment, retention and overall trial success.
As the Union Budget approaches, the lifesciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). The lifesciences sector in India has shown remarkable resilience […]
The same is true in lifesciences. As the technology develops, however, it will offer more opportunities to expedite drug discovery processes, streamline clinicaltrials, and speed up regulatory approvals. MGI puts the value of this contribution to clinical development at $15 billion to $25 b illion.
The expansion will also contribute to building the province of Ontarios position as a global hub for lifesciences and biotechnology. Additionally, AstraZeneca anticipates seven first Phase III clinicaltrial data readouts in 2025.In The acquisition was one of the largest research investments in a Canadian biotech firm.
This prestigious acknowledgment places Cloudbyz among the top-performing companies globally, known for delivering scalable and intuitive CTMS solutions that empower clinicalresearch teams. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”
This Act is poised to significantly change the clinicaltrials landscape within the lifesciences sector. As AI increasingly becomes a cornerstone in clinicalresearch and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation.
Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care. The Psoriasis Diet Diet has long been an area of research as a potential factor in managing psoriasis.
In clinicalresearch, diversity is more than a prerequisite for a successful drug — it’s a critical component that enhances the validity and applicability of clinicaltrial outcomes. Diversity Action Plans have now moved from being a “nice-to-have” to a “must-have” in clinicaltrial designs.
In this episode, Vera spoke with Morgan Hanger, Executive Director of the ClinicalTrials Transformation Initiative (CTTI). CTTI is a public-private partnership dedicated to improving the quality and efficiency of clinicaltrials, with an ambitious “Transforming Trials 2030” vision.
In the lifesciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all lifesciences subsidiaries are located in the US. After all, around a third of the world’s leading lifesciences corporations have their headquarters in the country. Industry clusters.
GSK has entered a strategic partnership with Wave LifeSciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.
Clinicaltrials have been steadily leaving the UK for years. of patients recruited to global trials were from the UK. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed. In 2021, just 2.2%
This year, Camargo is highlighting one of our own, Manager of LifeScience Solutions Andrea Miller, who cared for her husband Tom throughout his battle with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. We wanted to participate in a clinicaltrial. And I started researchingtrials.
The lifescience industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.
In the dynamic world of lifesciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its LifeSciences Cloud marks a significant stride towards this goal.
Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.
LifeSciences Council. Do you know about the LifeSciences Council (LSC)? The LSC has a website on Gov.uk, but the page says LifeSciences Council. A post from the director of health and lifesciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.
From enabling patient choice during clinicaltrials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables lifesciences teams to collaborate efficiently and effectively in 2023. Safety will create a single source of truth for content management.
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinicaltrials.
Changes taking place in the United States and internationally may affect the clinicaltrials landscape in the months and even years to come. … The post Keeping ClinicalTrials on Track: Navigating Supply Chains, Tariffs, and Regulatory Shifts. appeared first on Imperial ClinicalResearch Services Blog. .…
Most of us have heard of ChatGPT and AI but where and how do they fit into the lifesciences ecosystem? Over the next two years, GlobalData’s thematic research unit shows further advancements in machine learning, falling into three main categories: technology, macroeconomic, and regulatory. Can AI transform document translation?
Courtney Silverthorn PhD, the associate vice president of translational sciences at the FNIH, said that the BGTC plans to “bring some more standardisation and clarity to the pathway of how you get an AAV gene therapy into a first-in-human clinicaltrial [for rare diseases].”
OncoImmune was founded in 2000 based on the scientific discoveries of the company’s founders who moved their lead product from a basic concept into clinicaltrials for multiple indications. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
BlueRock Therapeutics, a subsidiary of Bayer AG, is making waves in the treatment of Parkinsons disease by advancing its investigational cell therapy, bemdaneprocel, to a Phase III clinicaltrial. In the Phase I trial, 12 participants received the therapy and were observed for two years. As of 2023, there were approximately 2.7
The company plans to use these funds to advance its groundbreaking research in small molecule precision medicines, targeting renal, cardiovascular and metabolic diseases, including obesity. Maze initiated the Phase I trial in 2024, with results expected in 2025. for an upfront payment of $150 million.
Optum LifeSciences expert provides insights on the latest trends. For manufacturers developing GLP-1s or in the market, its invaluable to understand the nuances of how real-world evidence (RWE) can be harnessed to demonstrate the clinical and economic value of weight loss medications.
Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. The company strengthens the translational research collaboration between the US and Ireland.
Whether it’s for a treatment for a chronic ambulatory condition, precision medicine or cell and gene therapy, there is a massive uptick in clinicaltrial complexity. It’s important to make sure that with this increase in clinicaltrial complexity, we don’t make our trials overly burdensome to sites or patients,” says Markham.
Recruiting participants is perhaps the most challenging aspect of any clinicaltrial, regardless of the therapeutic area. Yet this one piece is also the most vital, with a trial’s ability to enroll and retain participants being a key predictor of a study’s future success. What is ClinicalTrials For All?
As advancements in research forge ahead, it is imperative to ensure patients are informed about and can access potentially life-saving clinicaltrials. At the forefront of these efforts is Andrea Goodman, who was the Senior Vice President of Patient Support and Research Strategy at the Colorectal Cancer Alliance.
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinicaltrial space. Hybrid or decentralised clinicaltrials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.
This variability not only poses challenges for diagnosis but also stresses the need for targeted research and innovative therapeutic approaches. By exploring rare diseases and focusing on HPP, we can better understand the complexities of genetic disorders and the need for patient-centric research and collaboration.
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinicaltrials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinicaltrial design that have historically led to trial failure?
In this Xtalks Spotlight edition, Xtalks spoke with two oncology clinicalresearch experts from Fortrea , Laura Vidal, MD, Medical Head of Oncology, EU (European Union), and Ken Morrison, PhD, Global Head of Strategic Delivery & Growth Oncology. It’s very positive and it’s going to help move forward the pathway for new drugs.”
Clinicaltrial manager jobs are vital for the development and execution of clinicaltrials, which are essential for developing new treatments for diseases. In this article, we discuss the job duties, education and experience requirements, outlook and salary expectations for clinicaltrial managers.
The push to increase diversity in clinicaltrials has gained momentum, but true progress requires more than regulatory mandates. In this webinar, industry leaders and patient advocates discussed how authenticity and the patient voice can be leveraged to enhance diversity in clinicaltrials.
The Foundation for the National Institutes of Health (FNIH) announced this week that the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC) has selected eight rare diseases for its clinicaltrial portfolio.
Following the success of Issue 3 , which focused on the critical importance of patient diversity in clinicalresearch, Xtalks is thrilled to announce Xtalks Clinical Edge Issue 4. These prominent leaders will share their experiences, strategies and visions about whats next for clinicalresearch.
“The time for pontification is over when it comes to improving diversity in the clinicaltrial population,” says Reginald Swift, PhD, founder and CEO of Rubix LifeSciences. Industry has been too traditional in its thinking about how to truly promote patient diversity in the clinicaltrial population, he says. “We
In clinicalresearch, this includes designing trials that elevate the patient voice, reduce barriers to participation, and represent the diverse populations who will ultimately use these medical products. This distrust is further compounded by a lack of visible accountability and representation in the research process.
NORD, along with its more than 330 member patient organizations, is “committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.”. Can you tell us a bit about the work you are doing at NORD and how it impacts clinicaltrials for rare diseases?
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content